as on December 20, 2025 at 2:29 am IST
Day's Low
Day's High
5.84%
Downside
0.94%
Upside
52 Week's Low
52 Week's High
56.12%
Downside
60.26%
Upside
Check Insight Molecular Diagnostics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$86.7M
EPS (TTM)
-0.99
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-428.96%
Compare market cap, revenue, PE, and other key metrics of Insight Molecular Diagnostics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $86.7M | NA | NA | 0.00% | |
| BUY | $55.8B | 44.25% | 55.24 | 24.65% | |
| BUY | $37.9B | 22.34% | 30.65 | 8.07% | |
| BUY | $211.3B | 21.67% | 32.47 | 15.02% | |
| BUY | $38.8B | 15.04% | 30.02 | 18.75% |
Search interest for Insight Molecular Diagnostics Inc Stock has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, IMDX stock has moved up by 7.8%
Best in 1 Year
![]()
In the last 1 year, IMDX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Idexx Laboratories, Inc. has given 69.6% return, outperforming this stock by 77.8%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 2.13M → 260.0K (in $), with an average decrease of 62.8% per quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, -6.67M → -10.85M (in $), with an average decrease of 28.7% per quarter
| Organisation | Insight Molecular Diagnostics Inc |
| Headquarters | 2 International Plaza Dr., Nashville, TN, United States, 37217 |
| CEO | Mr. Joshua Riggs |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Joshua Riggs | President, CEO & Director |
Ms. Andrea Susan James | Chief Financial Officer |
Mr. Peter Hong | VP, General Counsel & Secretary |
Ms. Gabrielle Woody | Sr. Executive Assistant |
Mr. James Liu | VP of Accounting, Treasurer, Controller & Principal Accounting Officer |
Dr. Ekkehard Schutz M.D., Ph.D. | Chief Science Officer |
Mr. Yuh-Min Chiang Ph.D. | Chief Technology Officer |
Ms. Sandra O'Donald | Senior Vice President of Business Operations |
Dr. Paul R. Billings FACP, M.D., Ph.D. | Consulting Chief Medical Officer |
Dr. Michael D. West Ph.D. | Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc. |
Insight Molecular Diagnostics Inc share price today is $5.31 as on at the close of the market. Insight Molecular Diagnostics Inc share today touched a day high of $5.36 and a low of $5.
Insight Molecular Diagnostics Inc share touched a 52 week high of $8.51 on and a 52 week low of $2.33 on . Insight Molecular Diagnostics Inc stock price today i.e. is closed at $5.31,which is 37.60% down from its 52 week high and 127.90% up from its 52 week low.
Insight Molecular Diagnostics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Insight Molecular Diagnostics Inc (IMDX) shares with as little as ₹89.552 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Insight Molecular Diagnostics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Insight Molecular Diagnostics Inc share’s latest price of $5.31 as on December 20, 2025 at 2:29 am IST, you will get 1.8832 shares of Insight Molecular Diagnostics Inc. Learn more about
fractional shares .